NFTRH+; weekly chart analysis of two US sectors and one global market
Just because I happened to be working on the (weekly) chart and find the patterns interesting, I thought I'd pop the chart up here for your review. While sectors normally…
Just because I happened to be working on the (weekly) chart and find the patterns interesting, I thought I'd pop the chart up here for your review. While sectors normally…
I added back Biotech related DVAX yesterday, noting a short-term bottoming pattern (trade log): "As for the chart, the daily has a little hint of a short-term bottoming pattern if…
I am keeping an eye on the Biotech sector as IBB starts to make a move. I'm not watching it to buy it but rather, because I've already bought it…
Well, a bear looking to get short would hope for a market bounce and so, here is a market bounce. I shorted IBB this morning (per the Trade Log) and…
We track the Biotech iShares each week, and here is the up to the minute view of a constructive situation breaking to a bullish one. From NFTRH 514 (I since…
A look at the general Healthcare ETF (XLV), which includes BioPharma, Devices/Equipment and Services shows it easing below the trend line. IHI is at lateral support and the SMA 50…
The Biotech iShares IBB shot up on some beneficial talk out of the Trump administration and, in my opinion, on beneficial Treasury yield dynamics. So it is no coincidence that…
Yesterday we got the surge and then the ease into the close. Today? Err... The weekly now targets 350, barring a harsh reversal over the next 2 days. GILD was…
It's been a long time coming for the Biotech sector that has for me included some stops and starts in AMGN, GILD and IBB itself. Some profits, some losses. But…
While I currently work with all sorts of macro-fundamental indicators and inter-market ratio charts, I started out just loving the act of creating and analyzing nominal stock and market charts.…
Sending to the entire subscriber base since this works as a macro-related update as well. First, a long-term chart we have reviewed on occasion showing leadership lost by big Bio…
This update on the Biotech iShares works as both an NFTRH+ update and a regular update.
For the purposes of our regular updating, a breakout here would indicate that speculative bullish money is spreading out to Biotech, which helps the rally’s internals and speculative inputs.
Biotech, an important momentum leader to the stock market, is going to need to think about finding support soon lest this become something more than routine. IBB has already made…
Yesterday we noted the Biotechs had lower to go, and lower they went. Typical of today's momo driven markets IBB took the express elevator right to the projected support zone…